CareTrust REIT (CTRE) Stock Forecast & Price Target
$8.54B
Market Cap
22.02
P/E
23.25
Forward P/E
62
Score
CTRE price $36.15 +0.70 +1.97%
Stocklytics score rationale: value 44, quality 73, growth 68.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 103942000 | 131115000 | 155376000 | 159056000 | 175689000 | 190195000 | 187506000 | 198599000 | 228261000 | 476586000 |
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, seniors' housing complexes, and other related medical real estate. It maintains a broad, nationwide portfolio of assets, all under long-term net lease agreements with an…
Consensus Buy from 15 analysts. Average price target $43.88, +21.4% versus the current price. Low $42.00. High $46.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $43.88 for CareTrust REIT (CTRE), 21.4% above the current price of $36.15. Of 15 analysts covering the stock, 13 rate it Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $42.00 |
|---|---|
| Average | $43.88 |
| High | $46.00 |
The average is 21.4% above the current price of $36.15.
Of 15 analysts, 13 rate CareTrust REIT Buy or Strong Buy, 2 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $1.55, revenue $514.66 million. 2027, EPS $1.67, revenue $627.06 million.
The Stocklytics Score for CTRE is 62 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$43.88 average, with a published range of $42.00 to $46.00.
The consensus is Buy from 15 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $1.55. The average revenue estimate is $514.66 million.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: CareTrust REIT · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$8.54B
Market Cap
22.02
P/E
23.25
Forward P/E
62
Score